Frank Jing

Frank Jing has a strong background in process development and manufacturing within the biotechnology industry. Frank is currently working at Tenaya Therapeutics as the Senior Director and Head of PD and PPO since February 2019. Previously, they held the position of Senior Manager, Process Development for Engineered GammaDelta CAR-T at Adicet Bio, Inc from January 2017 to February 2019. Prior to that, they worked as a Process Development and Manufacturing Manager, AAV at Adverum Biotechnologies, Inc. from June 2015 to December 2016. Frank also has experience as a Late Stage Process Development Engineer at Genentech from January 2013 to May 2015, and as a Senior Process Development Engineer at Astellas Pharma from October 2009 to December 2012. Frank began their career as a Process Development Engineer at MedImmune from August 2005 to October 2009.

Frank Jing has a Master of Science (MS) degree in Biotechnology with an Emphasis in Regulatory Affairs from The Johns Hopkins University. Prior to that, they completed a combined Bachelor of Science (BS) and Master of Science (MS) program in Chemical Engineering at UCLA.